Cargando…
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
Chimeric antigen receptors (CARs) are recombinant receptors that combine the specificity of an antigen-specific antibody with the T-cell’s activating functions. Initial clinical trials of genetically engineered CAR T cells have significantly raised the profile of T cell therapy, and great efforts ha...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177696/ https://www.ncbi.nlm.nih.gov/pubmed/25241075 http://dx.doi.org/10.1186/1476-4598-13-219 |